Today: 20 May 2026
Chevron stock price steadies near $167 after oil slides; CVX traders eye Venezuela shift, earnings next week

Chevron stock price steadies near $167 after oil slides; CVX traders eye Venezuela shift, earnings next week

New York, Jan 22, 2026, 19:48 EST — After-hours

  • Chevron ended the day at $166.66, slipping 0.04%; after-hours trading showed minimal movement
  • Oil slipped to its lowest level in a week, dragging energy stocks down as Friday’s session got underway
  • Venezuela supply updates and Chevron’s earnings call on Jan. 30 will be the next key events to watch

Chevron (CVX.N) shares closed Thursday marginally lower, slipping 0.04% to $166.66. After-hours trading showed little movement following the 4 p.m. close.

The stock has resumed tracking crude prices. Thursday’s decline in oil pared down the “risk premium”—the additional cost traders factor in amid geopolitical uncertainty—and that usually weighs on major integrated producers fast.

This is crucial now as investors weigh whether more barrels from sanctioned producers, particularly Venezuela, will enter global supply right as Chevron prepares to report its quarterly earnings.

Brent crude dropped $1.18, closing at $64.06 a barrel. U.S. West Texas Intermediate (WTI) fell $1.26 to $59.36. Ole Hansen, Saxo Bank’s chief commodity analyst, described the market as undergoing “a deflation of risk premium.” Meanwhile, IG’s Tony Sycamore said oil is holding “around $60 a barrel.” Reuters

U.S. Gulf Coast refiners Valero (VLO.N) and Phillips 66 (PSX.N) snapped up shipments of Venezuelan crude linked to Washington’s recent accord with Caracas, sources told Reuters. The purchases came through Chevron, PDVSA’s partner, with these deals representing some of the first U.S. buys from newly licensed trading houses now allowed to market Venezuelan oil, according to the report.

Thursday saw drafts obtained by Reuters revealing Caracas is pushing to revamp Venezuela’s hydrocarbons law. The plan would let companies run oilfields under a new contract system, sell output directly, and keep proceeds even as minority partners in PDVSA. National Assembly chief Jorge Rodriguez backed the move, stating, “Oil beneath the ground is useless.” He added the proposal could lower royalty rates to as little as 15% for certain projects. Reuters

For Chevron, these shifts aren’t theoretical. Changes in the marketing of Venezuelan crude could reroute supplies to U.S. refineries and, crucially, shift global supply expectations at the margins.

Chevron is set to take center stage next week. The energy giant will host its fourth-quarter earnings call on Friday, Jan. 30 at 11:00 a.m. ET, a Business Wire advisory confirms. CEO Mike Wirth and CFO Eimear Bonner are expected to lead the discussion.

Chevron’s shares have climbed roughly 9.8% so far this year, maintaining their usual pattern of moving closely with oil prices on a daily basis.

The downside risk is right there in the headlines. If crude continues to fall amid easing geopolitical tensions or if more supply enters the market — from Venezuela or other sources — the sector’s support could evaporate quickly.

Chevron’s Jan. 30 earnings and conference call come next, with investors keen to hear about cash return plans and management’s outlook on crude-linked earnings through 2026.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900
Previous Story

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week
Next Story

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week

Go toTop